Skip to main content
. 2020 Sep 3;20(5):193. doi: 10.3892/ol.2020.12055

Figure 4.

Figure 4.

RFS for patients with each subtype of breast cancer after surgical therapy, stratified by the MME status. (A) Luminal type, (B) TNBC type and (C) other types. MME in the luminal subtype was associated with RFS (P=0.034) but this was not the case for MME in the TNBC subtype and other types (P=0.890 and P=0.977, respectively). MME, membrane mesothelin expression; RFS, relapse-free survival; TNBC, triple-negative breast cancer.